Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Implementing zero based budgeting strategies can empower families to take control of their finances. Discover ways to achieve your financial goals.
20,150 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
A deep dive into MiB: Bill Gurley, Benchmark—how a pioneering VC built a team culture, backed Uber and other giants, ...
A sudden 47% rise in Structure Therapeutics stock has traders buzzing while a major fund exits a multi-million dollar...
SpaceX just went public, unlocking new liquidity and a brighter spotlight on space-tech breakthroughs. This guide exp...
A dramatic rise in sandisk stock skyrocketed 857% in the first half of 2026 captured investors’ attention. This artic...
MercadoLibre fell in February amid margin concerns and tougher competition in LATAM. This article breaks down the for...
A landmark federal lawsuit against OpenAI puts AI liability in the spotlight. This article explains what it means for...
Markets have danced to a rhythm of inflation worries and policy signals. This article breaks down what president dona...
In a world of slim yields, five dividend stocks yielding more than 5% offer a chance for meaningful passive income. T...
A new AI risk assessment shows programmers face high displacement risk, upending traditional SaaS models and pressuri...
Brookfield's 2026 earnings path blends renewable energy growth with infrastructure and asset management fees. This gu...
A recent insider move at Lindblad Expeditions Holdings drew attention from investors. This article breaks down what h...